Medtronic Initiates Urgent Recall of Pipeline Vantage Embolization Devices Following Reports of Fatalities and Injuries
WASHINGTON — The U.S. Food and Drug Administration has classified a recent recall of certain Medtronic embolization devices as serious, following multiple fatalities linked to their use. Medtronic’s Pipeline Vantage 027 models have been recalled and pulled from the market, while updated usage instructions have been issued for the Pipeline Vantage 021 models. These devices are utilized in medical procedures to address aneurysms in the brain, which are dangerous bulges in artery walls. Medtronic’s Pipeline …